Evaluation of four chatbots in autoimmune liver disease: A comparative analysis

Jimmy Daza 1, Lucas Soares Bezerra 1, Laura Santamaría 2, Roberto Rueda-Esteban 2, Heike Bantel 3, Marcos Girala 4, Matthias Ebert 5, Florian Van Bömmel 6, Andreas Geier 7, Andres Gomez Aldana 8, Kevin Yau 9, Mario Alvares-da-Silva 10, Markus Peck-Radosavljevic 11, Ezequiel Ridruejo 12, Arndt Weinmann 13, Andreas Teufel 14 Affiliations Autoimmune liver diseases (AILDs) are rare and challenging to evaluate, prompting the exploration of chatbots as clinical decision support tools. This study involved ten liver specialists who systematically assessed four chatbots—ChatGPT 3.5, Claude, Microsoft …

Beitrag 3

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, …

Beitrag 2

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, …

Beitrag 1

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, …